Frontida Biopharm, Inc. — Form D

Frontida Biopharm, Inc. of EXTON, PA, a company, filed a Form D exempt-offering notice with the SEC on 2016-08-09. The offering totals $10.0M, of which $8.3M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2016-08-09
• Form: D
• Accession: 0001680898-16-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $10.0M
• Amount sold: $8.3M
• Remaining: $1.6M
• Minimum investment: $10K
• Investors: 21
• Date of first sale: 2016-05-31
• Security types: equity
• Revenue range: $5,000,001 - $25,000,000
• SEC file number: 021-268591

Issuer

• Name: Frontida Biopharm, Inc.
• CIK: 0001680898
• Entity type: Corporation
• Jurisdiction: PENNSYLVANIA
• Incorporated: 2015
• Address: 700 PENNSYLVANIA DRIVE, EXTON, PA, 19341
• Phone: 4843484802

Officers, directors & promoters (1)

More

• CIK 1680898 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search